(Q35236089)

7 August 2017

1 reference

title

The immune system in disease: gestational trophoblastic tumours (English)

1 reference

7 August 2017

Newlands ES

1

1 reference

7 August 2017

Fisher RA

series ordinal

2

1 reference

7 August 2017

Searle F

series ordinal

3

1 reference

7 August 2017

publication date

1 September 1992

1 reference

Bailliere's clinical obstetrics and gynaecology

7 August 2017

published in

1 reference

7 August 2017

volume

6

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

519-539

1 reference

Risk and prognostic factors in trophoblastic neoplasia

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Hydatidiform mole in England and Wales 1973-83.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Human chorionic gonadotropin β-subunit is encoded by at least eight genes arranged in tandem and inverted pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Origin and occurrence of human chorionic gonadotropin beta-subunit core fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The Heterogeneity of Human Chorionic Gonadotropin (hCG). III. The Occurrence and Biological and Immunological Activities of Nicked hCG*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Surgery and chemotherapy in the management of placental site tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Metastasizing placental site trophoblastic tumor: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Complete hydatidiform moles combine maternal mitochondria with a paternal nuclear genome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Gestational and nongestational trophoblastic tumors distinguished by DNA analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Choriocarcinoma in mother and child. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Cosmid mapping of the human chorionic gonadotropin beta subunit genes by field-inversion gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Efficacy of the metastatic survey in the staging of gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Amplification or rearrangement of the beta-human chorionic gonadotrophin (beta-hCG)--human LH gene cluster is not responsible for the ectopic production of beta-hCG by bladder tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Mechanism of origin of complete hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Gonadotropin and thyrotropin alpha- and beta-subunit gene expression in normal and neoplastic tissues characterized using specific messenger ribonucleic acid hybridization probes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Androgenetic origin of hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

XY and XX complete moles: clinical and morphologic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Serum HCG beta-core fragment is masked by associated macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Role of the beta 93-100 determinant loop sequence in receptor binding and biological activity of human luteinizing hormone and chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Clinical characteristics of placental site trophoblastic tumor (PSTT).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

HLA and trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Genetic studies on hydatidiform moles. I. The origin of partial moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Genetic studies on hydatidiform moles II. The origin of complete moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

A prospective genetic study of complete and partial hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Complete hydatidiform mole in Hawaii: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Isolation of fetal trophoblast cells from peripheral blood of pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Dispermic origin of XY hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Human chorionic gonadotropin and rat mammary cancer prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Pulmonary embolism, pulmonary hypertension, and choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Tetraploid conceptus with three paternal contributions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Tetraploid partial hydatidiform moles: two cases with a triple paternal contribution and a 92,XXXY karyotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Hydatidiform mole: cytogenetically unusual cases and their implications for the present classification

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Androgenesis as a Cause of Hydatidiform Mole 2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

The propensity to malignancy of dispermic heterozygous moles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Complete moles have paternal chromosomes but maternal mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980009-4

7 January 2021

10.1016/S0950-3552(05)80009-4

Identifiers

DOI

1 reference

7 August 2017

1 reference